Insider Transactions in Q1 2023 at Ab Cellera Biologics Inc. (ABCL)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 22
2023
|
Carl L. G. Hansen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
56,125
+10.0%
|
$112,250
$2.7 P/Share
|